| 物质名称 | DAUNORUBICIN CITRATE |
|---|---|
| 异名/同义词 | 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1) 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1) (SALT) DAUNORUBICIN CITRATE DAUNORUBICIN CITRATE [MART.] DAUNORUBICIN CITRATE [ORANGE BOOK] DAUNORUBICIN CITRATE [WHO-DD] DAUNORUBICIN CITRATE LIPOSOME DAUNORUBICIN CITRATE LIPOSOME [VANDF] DAUNORUBICIN LIPOSOMAL DAUNOXOME |
| CAS登记号 | 371770-68-2 |
| 物质唯一标识(Unique Ingredient Identifier) | 5L84T2Z6NP |
| 分子式 | C27H29NO10.C6H8O7 |
| 国际化合物标识(International Chemical Identifier,InChI) | VNTHYLVDGVBPOU-QQYBVWGSSA-N |
| SMILES | c12c(C(=O)c3c(OC)cccc3C1=O)c(O)c4c(c2O)C[C@](C[C@@]4(O[C@@H]5O[C@@H](C)[C@H]([C@H](C5)N)O)[H])(C(=O)C)O.C(CC(=O)O)(CC(=O)O)(C(=O)O)O |
| 分子结构式 |  |
| 欧洲化学品管理局注册号(ECHA) | |
| 成分类型 | INGREDIENT SUBSTANCE / chemical |
| 关联数据 |
|
| 扩展资源 |